Two industry-sponsored studies investiaged needs of people with pulmonary hypertesion and interstitial lung disease.

Pulmonary hypertension (PH), a serious lung and heart condition, elevates blood pressure in lung arteries, causing shortness ...

Advancements and Projections in the Global Pulmonary Arterial Hypertension Market: Insights, Trends, Opportunities, and ...

Winrevair lowered death or transplant risk in adults with PAH functional class 3-4 at high risk of dying; all in study may ...

Under the commercialisation agreement with Getz Healthcare, Beyond Air is set to obtain a $1m milestone payment.

While a check-in kiosk in healthcare settings may benefit some, it can pose challenges for older adults, columnist Colleen Steele says.

New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.

Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, ...

XOMA Royalty Corp. (XOMA), a biotechnology royalty aggregator, Monday announced that it now owns royalty and milestone interest in ...

Positive study results for Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent ...

Royalty Corporation now owns an economic interest in seralutinib, a Phase 3 asset being studied in pulmonary arterial hypertension ...

Recent health news highlights major developments in pharmaceuticals, including Merck's promising Winrevair for pulmonary ...